News
News from us and our partners
Tags
Topics
0 results
- News
Cellucomp Plant Opened by Annabelle Ewing MSP
- News
ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014
- News
Lysogène, University of Massachusetts Medical School and Auburn Unniversity announce collaboration agreement
- News
Comet Biorefining Secures Funding Led By Sofinnova Partners
- News
Sofinnova Partners’ portfolio company GlycoVaxyn sold to GlaxoSmithKline for $212 M in an all-cash deal
- News
Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- News
Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- News
Promising Phase I interim data for ExPEC vaccine program triggers first milestone payment in clinical co-development with Janssen
- News
Promising Phase I interim data for ExPEC vaccine program triggers first milestone payment in clinical co-development with Janssen
- News
Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil
- News
Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil
- News
Mission appoints Anker Lundemose as Chief Executive Officer
- News
Shockwave Medical Announces CE Mark Approval of its Lithoplasty System for the Treatment of Peripheral Artery Disease